Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. S3-Leitlinie Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms Langversion 1.0 – Februar 2018 AWMF-Registernummer: 020/007OL
2. Hammerschmidt S, Wirtz H (2009) Lungenkarzinom – aktuelle Diagnostik und Therapie. Dtsch Arztebl Int 106(49):809–820
3. Ettinger DS, Aisner DL, Wood DE, Akerley W, Bauman J, Chang JY, Chirieac LR, D’Amico TA, Dilling TJ, Dobelbower M, Govindan R, Gubens MA, Hennon M, Horn L, Lackner RP, Lanuti M, Leal TA, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Patel SP, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Stevenson J, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M (2018) NCCN guidelines insights: non small cell lung cancer, version 5.2018. J Natl Compr Canc Netw 16(7):807–821
4. Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, Mok TS, Reck M, Van Schil PE, Hellmann MD, Peters S, ESMO Guidelines Committee (2018) Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(Supplement_4):iv192–iv237
5. van Tinteren H et al (2002) Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 359(9315):1388–1393